Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: The impact of expensive chemotherapy

Keyphrases

• Allergy 50%
• Chemotherapy 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• Cost Analysis 100%
• Day Care 10%
• Decision Sensitivity 10%
• Decision Tree Analysis 20%
• Dutch 10%
• Erwinia Asparaginase 50%
• Escherichia Coli 70%
• First-line Drugs 10%
• High-cost Drugs 10%
• Immunogenic 10%
• L-asparaginase 100%
• Media Risk 10%
• Oncology 10%
• Overall Cost 10%
• Patient-level Data 10%
• Pegaspargase 90%
• Sensitivity Analysis 20%
• Treatment Costs 10%

Immunology and Microbiology

• Decision Trees 28%
• Erwinia 71%
• Escherichia coli 100%
• High Risk Population 14%